Intellectual PropertyRSS

  • August 21, 2006

    No End In Sight In Plavix Battle

    Attorneys spent a second day in court Monday arguing over whether Apotex’ generic version of the blockbuster blood thinner Plavix should be allowed on the market.

  • August 21, 2006

    eBay Case Doesn’t Affect Preliminary Injunctions: Judge Rules

    A federal judge has ruled that a landmark Supreme Court decision involving eBay only relates to permanent injunctions and not preliminary ones.

  • August 21, 2006

    Lengthy Patent Battle Wages On For Microsoft

    Timeline Inc. announced Monday that it has terminated a limited license with Microsoft Corp. for use of its patents with the software giant’s SQL Servers, and has asked a federal court to add Microsoft to a patent infringement lawsuit.

  • August 18, 2006

    DexCom Scores Stay, Partial Dismissal In Abbott Suit

    DexCom Inc. revealed Friday that it received a favorable ruling in a patent infringement dispute with rival Abbott Diabetes Care Inc. over technology related to glucose monitors used by diabetics.

  • August 18, 2006

    Jury Bats Down Synthon’s Claim Against Pfizer

    In another victory for brand name drug companies, a federal jury has rejected Dutch generics maker Synthon IP Inc.’s claim that Pfizer Inc.’s blockbuster blood pressure drug Norvasc violates its intellectual property.

  • August 18, 2006

    RFID Case Pits Inventor Against Six Corporate Giants

    A tiny Houston-based company has dragged five corporate giants into federal court in Texas, claiming they infringed on a patent related to miniscule microchips used to keep track of inventory.

  • August 18, 2006

    EchoStar Wins Block Of Damaging DVR Injunction

    The U.S. Courts of Appeals for the Federal Circuit Friday blocked a temporary injunction that would have prevented Echostar Communication Corp. from selling some of its digitial video recorders and stopped the service of about 4 million DVRs within 30 days.

  • August 18, 2006

    Class Action Suits Follow FTC Ruling Against Rambus

    Class action suits are popping up, following the U.S. Federal Trade Commission’s decision that technology-licensing company Rambus Inc. violated antitrust laws and deceived a group responsible for establishing industry-wide standards for memory-chip equipment.

  • August 18, 2006

    In Gleevec Feud, Novartis Targets Indian Patent Rules

    In its ongoing battle to patent its cancer treatment Gleevec in India, Novartis AG has lashed out not only at the rejection of its patent application earlier this year, but at a key section of India’s recently enacted patent laws.

  • August 18, 2006

    Gloves Come Off In Plavix Battle

    Canadian generic drug maker Apotex has accused Bristol-Myers of engaging in illegal secret side deals that led to a Department of Justice investigation into a Plavix settlement agreement.

  • August 18, 2006

    PTO Rejects 15 Claims In Synopsys Patent

    Magma Design Automation Inc. got a piece of good news when the U.S. Patent and Trademark Office rejected all 15 claims in one of three patents at issue in the suit between Magma and rival Synopsys Inc.

  • August 17, 2006

    Honeywell $46.58 Million Jury Verdict Overturned

    A federal judge has overturned a $46.58 million jury verdict in a patent infringement case from 2001 over aircraft power unit systems.

  • August 17, 2006

    Network Security Company Files Suit Against Rival

    DeepNines Inc., a network security solutions company, is suing rival McAfee Inc. for patent infringement in an attempt to permanently stop McAfee from selling a network security device.

  • August 17, 2006

    Ranbaxy Bids For Second Look In Lipitor Feud

    Swiping back in the battle over Pfizer Inc.’s Lipitor, Indian drug maker Ranbaxy Laboratories Ltd. on Wednesday asked a U.S. appeals court to reconsider part of a ruling that would block a generic version of the cholesterol medicine from hitting the market until 2010.

  • August 17, 2006

    Trial Slated For Monday In Wyeth Hormone Drug Case

    The first of thousands of personal injury lawsuits against Wyeth over the company’s hormone therapy drugs, which were used to treat the symptoms of menopause, is slated to begin on Monday.

  • August 17, 2006

    Symbol Settles Dispute Over Batteries

    In another electrifying win for the company, Symbol Technologies Inc. put the finishing touches on its settlement with Global Technology Systems over an intellectual property dispute relating to GTS’ Honeywell batteries.

  • August 17, 2006

    IP Partner Comes To Dechert By Way Of South Korea

    Signing on as the new partner in Dechert LLP’s Austin, Tex. office was a homecoming of sorts for Steven R. Daniels—and not just because he recently returned from South Korea.

  • August 16, 2006

    In HIV/AIDS Fight, Tough Choices Loom For Thailand

    Weeks after protestors rallied against British drug maker GlaxoSmithKline’s efforts to patent an anti-retroviral in Thailand, the World Bank warned in a report Wednesday that the country must decide whether to shell out market prices for patented drugs as a rising number of Thais living with HIV/AIDS are forced to turn to so-called second-line drugs.

  • August 16, 2006

    Fish & Richardson Nets Seasoned Litigator

    Before coming to Fish & Richardson PC earlier this month, 67-year-old IP lawyer Jonathan A. Marshall briefly considered retirement. His firm, Weil Gotshal & Manges, required its attorneys to step down once they hit 68, an age at which not many people are thinking of starting over in a new position.

  • August 16, 2006

    Bristol-Myers, Sanofi Try To Cope With Generic Plavix

    In an attempt to cope with Apotex Inc.’s recent launch of generic Plavix, Bristol-Myers Squibb Co. and Sanofi-Aventis SA are offering the buyers of Plavix prices below the price of the generic version.